EPMN: on the move due to heightened investor confidence. EPMN is the only biotechnology that has conducted cancer vaccine research on humans, AND EVERY TEST SO FAR SUCCESSFUL. Real chance of having a commercially available vaccine from them very high, pretty promising potential IMO. Stock is on the move.